Lawrence Blacher, M.D., Memorial Lecture Evaluation - February 22, 2024

Please select one: *

I am in active clinical practice

I am retired

I am a student

Other

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients	The skills learned in this CME course will be applied in the treatment of my patients - 5	The skills learned in this CME course will be applied in the treatment of my patients - 4	The skills learned in this CME course will be applied in the treatment of my patients - 3	The skills learned in this CME course will be applied in the treatment of my patients - 2	The skills learned in this CME course will be applied in the treatment of my patients - 1	The skills learned in this CME course will be applied in the treatment of my patients - NA

How confident are you in your ability to: *

5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence

	5	4	3	2	1
Recognize clinical situations where amyloidosis should be seriously considered in differential.	Recognize clinical situations where amyloidosis should be seriously considered in differential. - 5	Recognize clinical situations where amyloidosis should be seriously considered in differential. - 4	Recognize clinical situations where amyloidosis should be seriously considered in differential. - 3	Recognize clinical situations where amyloidosis should be seriously considered in differential. - 2	Recognize clinical situations where amyloidosis should be seriously considered in differential. - 1
Apply evidence-based recommendations that enable accurate staging and counseling about prognosis.	Apply evidence-based recommendations that enable accurate staging and counseling about prognosis. - 5	Apply evidence-based recommendations that enable accurate staging and counseling about prognosis. - 4	Apply evidence-based recommendations that enable accurate staging and counseling about prognosis. - 3	Apply evidence-based recommendations that enable accurate staging and counseling about prognosis. - 2	Apply evidence-based recommendations that enable accurate staging and counseling about prognosis. - 1

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
Recognize clinical situations in which AL amyloidosis should be seriously considered in differential.	Recognize clinical situations in which AL amyloidosis should be seriously considered in differential. - 5	Recognize clinical situations in which AL amyloidosis should be seriously considered in differential. - 4	Recognize clinical situations in which AL amyloidosis should be seriously considered in differential. - 3	Recognize clinical situations in which AL amyloidosis should be seriously considered in differential. - 2	Recognize clinical situations in which AL amyloidosis should be seriously considered in differential. - 1
Weigh the merits of conventional and high-dose therapy as management for AL amyloidosis.	Weigh the merits of conventional and high-dose therapy as management for AL amyloidosis. - 5	Weigh the merits of conventional and high-dose therapy as management for AL amyloidosis. - 4	Weigh the merits of conventional and high-dose therapy as management for AL amyloidosis. - 3	Weigh the merits of conventional and high-dose therapy as management for AL amyloidosis. - 2	Weigh the merits of conventional and high-dose therapy as management for AL amyloidosis. - 1
Apply evidence-based recommendations that allow for earlier diagnosis of this rare set of diseases and enable accurate staging and counseling about prognosis.	Apply evidence-based recommendations that allow for earlier diagnosis of this rare set of diseases and enable accurate staging and counseling about prognosis. - 5	Apply evidence-based recommendations that allow for earlier diagnosis of this rare set of diseases and enable accurate staging and counseling about prognosis. - 4	Apply evidence-based recommendations that allow for earlier diagnosis of this rare set of diseases and enable accurate staging and counseling about prognosis. - 3	Apply evidence-based recommendations that allow for earlier diagnosis of this rare set of diseases and enable accurate staging and counseling about prognosis. - 2	Apply evidence-based recommendations that allow for earlier diagnosis of this rare set of diseases and enable accurate staging and counseling about prognosis. - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so? *

Please provide any additional comments or suggestions.

Name

You are here

Lawrence Blacher, M.D., Memorial Lecture Evaluation - February 22, 2024